
    
      Group 1 will consist of low-risk participants with cHL Stages IA, IB and IIA without bulky
      disease. Group 2 will consist of high-risk participants with cHL Stages IIEB, IIIEA, IIIEB,
      IIIB, IVA and IVB.
    
  